Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Value dimension, with a Value rank ahead of 98.23% of US stocks.
• IRWD's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• IRWD ranks lowest in Momentum; there it ranks in the 5th percentile.

IRWD Stock Summary

• IRWD's current price/earnings ratio is 4.16, which is higher than just 3.95% of US stocks with positive earnings.
• IRWD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 72.07% of US stocks.
• As for revenue growth, note that IRWD's revenue has grown -3.24% over the past 12 months; that beats the revenue growth of merely 24.96% of US companies in our set.
• Stocks that are quantitatively similar to IRWD, based on their financial statements, market capitalization, and price volatility, are GKOS, MITK, NOVT, TUFN, and NBIX.
• Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• In comparison to the median Healthcare stock, IRWD's price/sales ratio is 36.84% higher, now standing at 5.2.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.
• Over the past 141 months, IRWD's EV/EBIT ratio has gone up 24.6.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

• Its 5 year cash and equivalents growth rate is now at -9.51%.
• Its 4 year net cashflow from operations growth rate is now at 236.25%.
• The year over year price growth rate now stands at 0.87%.

IRWD's revenue has moved up $278,703,000 over the prior 70 months.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	413.024	227.407	508.856
2021-03-31	398.425	198.927	142.757
2020-12-31	389.523	168.836	106.176
2020-09-30	399.144	144.903	110.83
2020-06-30	426.843	126.038	97.055
2020-03-31	439.626	96.713	84.134

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.85% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 677 Pharmaceutical Products stocks.
• LGND, IBIO, and COLL are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.